ATHENAGEN RAISES $5.69 MILLION IN SERIES A FINANCING

Athenagen, Inc., a privately held pharmaceutical company founded by two Stanford University scientists, announced today that it will accept a $5.69 million investment in its first round of financing. The investment consists of $3.19 million that closed last week and an additional funding commitment of $2.50 million upon reaching certain milestones within the next twelve months. The financing was led by Sanderling Ventures and included participation from Life Science Angels.

Yahoo News (http://biz.yahoo.com/prnews/050919/sfm039.html?.v=23)